Head-to-head · Cost-Efficiency Index
NovoCare Pharmacy vs Tablet Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
NovoCare Pharmacy
Patients who already have a Wegovy prescription and want the lowest-cost manufacturer-direct self-pay or insurance-copay price — not a fit for readers still looking for a prescriber.
Visit NovoCare PharmacyTablet Health
Cost-first shoppers who want an oral-tablet GLP-1 option at the lowest published tier ($179/mo), if you can tolerate no state-coverage list.
Visit Tablet HealthThe verdict
NovoCare Pharmacy and Tablet Health tie on the Cost-Efficiency Index at 57/100, so neither wins outright on the numbers. For most shoppers we'd start with NovoCare Pharmacy (ranked #309, a hair above #315) — Patients who already have a Wegovy prescription and want the lowest-cost manufacturer-direct self-pay or insurance-copay price — not a fit for readers still looking for a prescriber. But Tablet Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs NovoCare Pharmacy.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | NovoCare Pharmacy | Tablet Health |
|---|---|---|
| Cost-Efficiency Index | 57/100 | 57/100 |
| Semaglutide / mo | Not disclosed | $199/mo (compounded) |
| Tirzepatide / mo | Not disclosed | $299/mo (compounded) |
| Semaglutide / yr (modeled) | — | $2,388 |
| Tirzepatide / yr (modeled) | — | $3,588 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Yes | Compounded only |
| Rank here | #309 | #315 |
NovoCare Pharmacy
57/100Where the value is
- First-party Novo Nordisk program — the most authoritative source for actual Wegovy self-pay and insurance-copay pricing, with no telehealth-platform markup
- Commercially-insured patients can pay as little as $25/month, capped at $100/month in savings
- New oral 'Wegovy Pill' option now available from $149/month, in addition to the injectable pen
The tradeoffs
- This is NOT a telehealth or prescribing service — it requires a valid Wegovy prescription obtained elsewhere, with no consultation or clinical support included
- Introductory pricing is time-limited: the $199/month pen offer expires 12/31/2026 (reverting to $349/month) and the 4mg pill price updates 8/31/2026
Tablet Health
57/100Where the value is
- LegitScript Certified — seal displayed on the site
- Offers both oral-tablet and injectable forms of semaglutide AND tirzepatide, four distinct SKUs
- Published per-product pricing rather than a single vague 'starting at' figure: $179-$299/mo across the four variants
The tradeoffs
- States served are not published anywhere on the accessible site — eligibility is only revealed by completing the intake quiz
- The homepage's 'Flat monthly pricing starting at $149' banner cannot be tied to any of the four listed $179-$299 tiers
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.